ISOPROPYL ALCOHOL
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 60.0 | 0.4 | 1 | 1 | 20.0 | 0 | 1.0 |
- CAS
- 67630
- UNII
- ND2M416302
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 64 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02203591 | 2014-07-01 | In Vivo Patient Preoperative Preps Efficacy Study | Phase 3 | Completed |
| NCT01361997 | 2011-06-01 | Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination | Phase 3 | Completed |
| NCT01366417 | 2011-05-01 | Topical Antimicrobial Effectiveness Testing | Phase 4 | Completed |
| NCT01314703 | 2011-03-01 | Topical Antimicrobial Effectiveness Testing | Phase 4 | Completed |
| NCT01110772 | 2009-05-01 | Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation | Phase 4 | Recruiting |
| NCT00515151 | 2002-05-01 | Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride | Phase 4 | Completed |
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Intravenous | Injection | |
| Oral | Capsule | 46.4MG |
| Oral | Capsule, Delayed Action | |
| Oral | Capsule, Delayed Release | 300.5MG |
| Oral | Capsule, Extended Release | 183MG |
| Oral | Capsule, Hard Gelatin | |
| Oral | Capsule, Soft Gelatin | |
| Oral | Capsule, Sustained Action | 392.8MG |
| Oral | Powder, For Reconstitution | |
| Oral | Solution | |
| Oral | Tablet | 402.53MG |
| Oral | Tablet, Coated | |
| Oral | Tablet, Delayed Action, Coated | |
| Oral | Tablet, Delayed Action, Enteric Coated | 0.2MG |
| Oral | Tablet, Extended Release | 0.27MG |
| Oral | Tablet, Film Coated | |
| Oral | Tablet, Orally Disintegrating | |
| Oral | Tablet, Sustained Action | |
| Oral | Tablet, Sustained Action, Coated | |
| Oral-21 | Tablet | 2MG |
| Topical | Aerosol, Metered | 4% |
| Topical | Aerosol, Spray | 10% |
| Topical | Gel | 30% |
| Topical | Lotion | 78% |
| Topical | Lotion, Augmented | 30% |
| Topical | Oil | |
| Topical | Ointment | |
| Topical | Solution | 51.5% |
| Topical | Sponge | |
| Topical | Spray | 23.4% |
| Topical | Swab | |
| Transdermal | Patch, Electrically Controlled | |
| Transdermal | Solution | 28.76% |